Marinus Pharmaceuticals

United States
South Fork, Pennsylvania, United States, 06405

Company profile

Marinus Pharmaceuticals company profile

Marinus Pharmaceuticals focuses on creating therapies aimed at improving the lives of individuals affected by seizure disorders. The company emphasizes innovation through cutting-edge science and collaborates with healthcare professionals to enhance patient care.

Business identity

Contact email
[email protected]
Phone number
484-253-6792
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$1M-$10M
Founded
2003-01-01, Year

Headquarters

Postal code
06405
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
13
Total equity funding
$344.4M
Last funding
Post IPO Equity / $60M / 2022-11-07
Last equity funding
Post IPO Equity / $60M
Investors
8
Lead investors
6
Founders
1
Articles
199
Exited on
2014-07-31

Founders and investors

Founders

Harry H. Penner

Lead investors

Bain Capital Life SciencesCanaan PartnersDomain AssociatesOaktree Capital ManagementSagard Healthcare Royalty PartnersSofinnova Investments

Investors

Bain Capital Life SciencesCanaan PartnersDomain AssociatesOaktree Capital ManagementSofinnova Investments